Systemic protection through remote ischemic preconditioning is spread by platelet-dependent signaling in mice

Hepatology

Volumn 60, Issue 4, 2014, Pages 1409-1417

  Oberkofler, Christian E ^a   Limani, Perparim ^a   Jang, Jae Hwi ^a   Rickenbacher, Andreas ^a   Lehmann, Kuno ^a   Raptis, Dimitri A ^a   Ungethuem, Udo ^a   Tian, Yinghua ^a   Grabliauskaite, Kamile ^a   Humar, Rok ^a   Graf, Rolf ^a   Humar, Bostjan ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; NEUTROPHIL COLLAGENASE; PADGEM PROTEIN; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; VASCULOTROPIN; MMP8 PROTEIN, MOUSE; TPH1 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE; VASCULOTROPIN A;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VESSEL; CONTROLLED STUDY; GENE EXPRESSION; ISCHEMIC PRECONDITIONING; LIVER INJURY; MOUSE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; REMOTE ISCHEMIC PRECONDITIONING; REPERFUSION INJURY; SEROTONIN BLOOD LEVEL; SIGNAL TRANSDUCTION; STRESS; TARGET ORGAN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UPREGULATION; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; THROMBOCYTE; VASCULARIZATION;

ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; ISCHEMIC PRECONDITIONING; LIVER; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY; SEROTONIN; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; TRYPTOPHAN HYDROXYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927800476     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27089     Document Type: Article

References (39)

1. Cannon WB. Bodily Changes in Pain, Hunger, Fear and Rage (2nd ed). New York: D. Appleton & Co; 1929.
2. Misslin R. The defense system of fear: behavior and neurocircuitry. Clin Neurophysiol 2003;33:55-66.
3. Lesurtel M, Lehmann K, de Rougemont O, Clavien PA. Clamping techniques and protecting strategies in liver surgery. HPB 2009;11:290-5.
4. Jeon J, Watkins A, Wagener G, Samstein B, Guarrera J, Goldstein M, et al. Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes. W J Surg 2013;37:838-846.
5. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 2010; 97:1461-1475.
6. Rüdiger HA, Kang KJ, Sindram D, Riehle HM, Clavien PA. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg 2002;235:400-407.
7. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843-850.
8. Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727-734.
9. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007;370:575-579.
10. Kanoria S, Jalan R, Seifalian AM, Williams R, Davidson BR. Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation 2007;84:445-458.
11. Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001;33:100-113.
12. Oxman T, Arad M, Klein R, Avazov N, Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol 1997;273:H1707-H1712.
13. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Kwiecien S, Pawlik M, et al. Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves. Eur J Pharmacol 2004;499:201-213.
14. Park KM, Kramers C, Vayssier-Taussat M, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002;277:2040-2049.
15. Xia Z, Herijgers P, Nishida T, Ozaki S, Wouters P, Flameng W. Remote preconditioning lessens the deterioration of pulmonary function after repeated coronary artery occlusion and reperfusion in sheep. Can J Anesth 2003;50:481-488.
16. Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R, Clavien PA. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007;45:369-376.
17. Kennedy SE, Erlich JH. Murine renal ischaemia-reperfusion injury. Nephrology 2008;13:390-396.
18. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-107.
19. Kiefer FN, Munk VC, Humar R, Dieterle T, Landmann L, Battegay EJ. A versatile in vitro assay for investigating angiogenesis of the heart. Exp Cell Res 2004;300:272-282.
20. Brand T, Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 2011;57:1376-1386.
21. Penna C, Bassino E, Alloatti G. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. Exp Biol Med 2011;236:390-401.
22. Magro A. Serotonin, platelets, and vascular function Central and peripheral mechanisms of cardiovascular regulation, Springer. NATO ASI Series 1986;109:135-161.
23. Faleo G, Neto JS, Kohmoto J, Tomiyama K, Shimizu H, Takahashi T, et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008;85:1833-1840.
24. Furrer K, Rickenbacher A, Tian Y, Jochum W, Bittermann AG, Käch A, et al. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci U S A 2011;108:2945-2950.
25. Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, et al. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol 2008;295:H2308-H2314.
26. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007;171:53-67.
27. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Ann Rev Immunol 2011;29:71-109.
28. Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev 2006;17:217-223.
29. Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 1997;64:993-998.
30. Zhang N, Khachigian LM. Injury-induced platelet-derived growth factor receptor-alpha expression mediated by interleukin-1beta (IL-1beta) release and cooperative transactivation by NF-kappaB and ATF-4: IL-1beta facilitates HDAC-1/2 dissociation from promoter. J Biol Chem 2009;284:27933-27943.
31. Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 1987;60:20B-28B.
32. Hargrave B, Li F. Nanosecond pulse electric field activation of platelet-rich plasma reduces myocardial infarct size and improves left ventricular mechanical function in the rabbit heart. J Extra Corpor Technol 2012;44:198-204.
33. Barrabés JA, Garcia-Dorado D, Mirabet M, Inserte J, Agulló L, Soriano B, et al. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia. J Am Coll Cardiol 2005;45:293-299.
34. Solchaga LA, Bendele A, Shah V, Snel LB, Kestler HK, Dines JS, Hee CK. Comparison of the effect of intra-tendon applications of recombinant human platelet-derived growth factor-BB, platelet-rich plasma, steroids in a rat achilles tendon collagenase model. J Orthop Res 2014;32:145-150.
35. Aspenberg P. Stimulation of tendon repair: mechanical loading, GDFs and platelets. A mini-review. Int Orthop 2007;3:783-789.
36. Fu LW, Longhurst JC. Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors. J Physiol 2002;544:897-912.
37. Mao HZ, Li Z, Chapleau MW. Platelet activation in carotid sinuses triggers reflex sympathoinhibition and hypotension. Hypertension 1996;27:584-590.
38. Bucher HW, Stucki P. Norepinephrine-induced rise in circulating blood platelets and free fatty acids in arterial and venous blood of patients with ischaemic heart disease and controls. Helv Med Acta 1969;34:503-509.
39. Francesconi M, Scapin M, Casonato A, Girolami A, Deana R. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes. Thromb Res 2000;100:293-303.